KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 132 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $65,000 | +30.0% | 19,290 | +45.1% | 0.00% | 0.0% |
Q2 2018 | $50,000 | -23.1% | 13,290 | -16.4% | 0.00% | 0.0% |
Q1 2018 | $65,000 | -18.8% | 15,890 | -8.9% | 0.00% | 0.0% |
Q4 2017 | $80,000 | +33.3% | 17,440 | +109.0% | 0.00% | 0.0% |
Q3 2017 | $60,000 | -13.0% | 8,345 | -12.8% | 0.00% | 0.0% |
Q2 2017 | $69,000 | -76.6% | 9,565 | -80.0% | 0.00% | -83.3% |
Q1 2017 | $295,000 | -4.2% | 47,885 | -8.6% | 0.01% | -14.3% |
Q4 2016 | $308,000 | +51.7% | 52,390 | +37.7% | 0.01% | +40.0% |
Q3 2016 | $203,000 | -6.0% | 38,055 | +15.9% | 0.01% | -16.7% |
Q2 2016 | $216,000 | – | 32,830 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |